Purpose: To describe the indications, visual acuity outcomes, and graft survival after penetrating keratoplasty (PKP) in Addis Ababa, Ethiopia.
A lthough corneal opacity is a common cause of visual loss in developing countries, access to sight-restoring corneal transplantation remains challenging for many patients. 1 In resource-poor settings, management of penetrating keratoplasty (PKP) is complicated by a lack of supportive infrastructure such as eye banks and adequately equipped operating rooms. There may also be limited access to trained corneal surgeons and follow-up care, and little opportunity for corrective lenses for visual rehabilitation. 2, 3 The World Health Organization estimates that corneal blindness is the second leading cause of blindness among all age groups in Ethiopia and the leading cause of visual impairment among children and adolescents in that country. 4 To meet this need, an eye bank has been operating in the country since 2003-one of the few eye banks in Africa. Although a growing number of cornea fellowship-trained ophthalmologists are practicing throughout the country, most transplants are performed at the university hospital, Menelik II Eye Hospital in Addis Ababa. Given the challenges of implementing corneal transplantation in the developing world, we sought to document the outcomes of patients receiving corneal transplants at this hospital to guide surgeons throughout Africa as corneal transplantation becomes more available on the continent. In this study, we describe the indications for surgery, visual acuity outcomes, and graft survival in patients undergoing PKP in Addis Ababa, Ethiopia.
METHODS
The medical records of patients who underwent PKP at Menelik II Eye Hospital in Addis Ababa, Ethiopia, were retrospectively reviewed. All corneal transplants were performed by one of 2 experienced cornea-trained Ethiopian surgeons under local anesthesia with retrobulbar block. In most cases, the donor graft was oversized by 0.25 to 0.5 mm compared with the recipient, and a 16-bite interrupted suture technique was used. Postoperative care including timing of removal of graft sutures and tapering of topical antibiotics and steroids was at the discretion of the treating physician.
Data were collected including demographic information such as patient's age, sex, baseline visual acuity, surgical indication, and other ocular comorbid conditions. The primary study outcome was graft failure, defined as irreversible loss of graft clarity. Secondary outcomes included uncorrected visual acuity, and complication rates such as development of secondary ocular hypertension or glaucoma, infectious keratitis, graft rejection, endophthalmitis, and the need for subsequent surgery. Visual acuity was uncorrected unless the patient had access to spectacles, and no pinhole visual acuity was available. Ocular hypertension or glaucoma was defined as either a measured intraocular pressure greater than 25 or an observed increase in the cup-to-disc ratio.
Institutional review board approval for this study was obtained from the University of California, San Francisco and the Menelik II Hospital in Addis Ababa, Ethiopia. Informed consent was obtained from all study participants, and the study conformed to the Declaration of Helsinki. Graft survival curves were produced using the Kaplan-Meier method. The log-rank test was used to evaluate differences in survival based on the indication for surgery comparing graft survival in keratoconus (KCN) with all other indications. Cox proportional hazards models were used to assess the time to each complication by indication for surgery. Alpha , 0.05 was considered statistically significant. All data were analyzed with Stata 14.0.
RESULTS
A total of 332 patients underwent PKP between September of 2000 and September of 2013. The study population consisted of 173 men (52%) and 159 women (48%) and had a mean age of 33 (SD 19). Mean baseline uncorrected visual acuity was logarithm of the minimum angle of resolution (logMAR) 2.09 (SD 0.67, approximate Snellen 20/2400). Most transplants were performed for optical rather than therapeutic indications (N = 330; 99%), and half of those undergoing PKP could not pay for the services (N = 167, 50%). Table 1 outlines the indication for surgery, which was trachoma or postinfectious corneal opacity in 141 (44%), KCN in 45 (14%), corneal dystrophy in 46 (14%), pseudophakic or aphakic bullous keratopathy in 28 (9%), trauma in 27 (8%), previous graft failure in 18 (6%), active ulcer, burn, or perforation in 9 (3%), and other indications in 8 (2%).
Donor tissue for transplantation came from the Ethiopian eye bank in 92% (N = 307) of cases. The remaining donor tissue (N = 27) was donated from the United States, Poland, Czech Republic, and Paraguay. The most common cause of death among Ethiopian donors was trauma (N = 255; 83%), whereas it was cardiovascular disease among the donors of imported tissue (N = 13; 52%). The mean donor age of Ethiopian tissue was quite young at 29 years (SD 9), whereas that of imported tissue was 58 years (SD 12). Ethiopian tissue had a mean death to preservation time of 4.8 hours (SD 1.8) and death to implantation time of 6.9 days (SD 3.2); the corresponding numbers for imported tissue were 9.9 hours (SD 5.8) and 12 days (SD 3.1). Optisol was the most common storage medium (N = 328; 99%).
The mean endothelial cell count of imported tissue was 2708 (SD 489) as measured by the specular microscope at each respective institution. The mean endothelial cell count of donor grafts as measured by specular microscopy at the Ethiopian Eye Bank was 3539 cells/mm 2 (SD 637). The Ethiopian endothelial cell counts seemed to be remarkably high and although the donors were very young, which could account for this, it was believed that measurement errors were also possible. The average donor graft diameter was 8 mm (range 7-8.75 mm), and most grafts were performed with an interrupted versus running suture technique (N = 328; 99%). Eighty-four patients (25%) had concurrent extracapsular cataract extraction at the time of keratoplasty, an additional 8 had intraocular lens exchange, and 1 patient had intraocular lens explantation. The most common intraoperative complication was vitreous loss, which occurred 6% of the time (N = 20) .
Mean follow-up time for all study participants was 37 months (SD 21). There was at least 6-month follow-up available for 96% (N = 319) and 2-year data were available for 76% (N = 252). By 5 years, follow-up data were available for 26% (N = 85), and at 10 years postoperatively, data were available for 1% (N = 3). Figure 1 demonstrates the KaplanMeier curves for graft survival by indication for surgery. Graft survival including all available follow-up for all patients was 71% (N = 235). The graft survival rate was 95% at 6 months (N = 315), 89% at 1 year (N = 297), and 80% at 2 years (N = 266). Study participants who underwent PKP for KCN had a mean follow-up time of 46 months (SD 21). Their 2-year graft survival rate was 100% with follow-up data available for 89% of study participants (N = 40). Compared with KCN, all other indications had statistically significantly decreased 2-year graft survival including corneal dystrophy (78%, P , 0.001), previous graft failure (56%, P , 0.001), trauma (94%; P = 0.02), active ulcer/burn/perforation (86%; P , 0.001), trachoma/postinfectious corneal opacity (78%; P , 0.001), pseudophakic/aphakic bullous keratopathy (83%; P = 0.004), and all other indications (75%; P , 0.001). Figure 2 demonstrates the change in uncorrected visual acuity from baseline to 6 months and 2 years in logMAR for patients with follow-up of that duration. Mean uncorrected visual acuity at baseline was logMAR 2. 2.44-6.04; P , 0.001). There was no observed increased risk of graft failure among study participants who developed secondary glaucoma (hazard ratio 1.06, 95% CI 0.66-1.71, P = 0.8). Compared with imported tissue, those receiving Ethiopian prepared tissue had 0.62 decreased odds of graft failure, but this was not a statistically significant difference (95% CI 0.26-1.45; P = 0.27).
Complications varied somewhat by the indication for keratoplasty. As expected, previous graft failure conferred a greater risk of endothelial rejection compared with KCN (P , 0.001). Active ulcer, perforation, or corneal burn conferred a higher risk of infectious keratitis (P = 0.04) and FIGURE 2. Visual acuity change from (A) baseline to 6 months and (B) baseline to 2 years postoperatively. Kernel density plots showing the visual acuity change from baseline to 6 months and from baseline to 2 years in logMAR including only study participants with follow-up of that duration. Of note, lower numbers on the logMAR scale represent improvement in visual acuity.
endophthalmitis (P , 0.001) compared with study participants undergoing corneal transplant for KCN. All indications for surgery had similar rates of secondary glaucoma.
DISCUSSION
In this study of PKP outcomes in Ethiopia, we found that the indication for surgery was a statistically significant predictor of graft survival. The indication for surgery has been shown to be an important determinant of graft survival both in the United States 5 and internationally. 2, [6] [7] [8] Because patients undergoing PKP for KCN have an excellent prognosis, it has been suggested that graft survival in KCN can be used as a comparison between different centers and countries. 9 Graft survival of KCN in our series was excellent and quite comparable to that reported in other series. 9, 10 Grafts performed for other indications in Ethiopia had lower survival than KCN, which is likely due to the fact that most of them were performed for high-risk indications.
Graft survival was improved among study participants receiving Ethiopian tissue compared with donor tissue imported from other countries, although this difference was not statistically significant. The corneal donor study has demonstrated that donor age is a factor in graft survival; therefore, these results are probably related to the young age of donors in our series. 11 The elevated endothelial cell counts among Ethiopian donors in our study are assumed to be erroneous, possibly because of measurement errors at the eye bank.
The most common complications in our series were related to suture abscess and corneal ulceration. As expected, these complications were more common in high-risk grafts and those performed for therapeutic indications. Not surprisingly, study participants who had one such complication had a statistically significant increased risk of graft failure. Strategies to reduce infectious complications such as early suture removal, prolonged topical antibiotics, and close follow-up may reduce these complications in the future.
Limitations to this study include those common to all retrospective studies. Given the fact that our study was located in a resource-poor setting, there were some missing data in chart reviews, and patients had inconsistent follow-ups or were lost to follow-up altogether. However, 96% of our study participants had at least 6 months of follow-up and problems such as intermittent follow-up or different followup times are commonly managed with survival analysis, as was done in our study. Visual acuity outcomes in our study were imperfect because we did not have best-corrected visual acuity for most of our study participants because of a lack of access to glasses or contact lenses. Although this is a significant limitation, it represents real-life outcomes of corneal transplantation in resource-poor settings. The question of how to allocate resources such as spectacles versus corneal transplant to best improve vision-related quality of life in Ethiopia requires further study. A larger prospective study of corneal transplant outcomes in a setting such as Ethiopia will also be needed to confirm the findings in this study.
Corneal transplantation seems to be a viable treatment to address the high burden of corneal blindness in Ethiopia. Overall, there was postoperative improvement in visual acuity after corneal transplant in our series, which resulted in ambulatory vision or better for many of our patients. There is room for improvement in visual rehabilitation after transplant at our center as demonstrated by the low number of transplant recipients who had access to spectacles postoperatively and the lack of availability of contact lenses. This should be an important focus of corneal transplant management to improve upon in the future.
